MESO$15.163.25%-0.51
After Hours: 15.30+0.14 +0.92%
Mesoblast Ltd Adr (MESO)
Date: 2026-10-30 16:00O: 15.38H: 15.69L: 14.84C: 15.16Vol: 374.2k
Mesoblast Ltd Adr stock is traded at $15.16, with a volume of 374,187. It is down -3.25% in the last 24 hours and up +3.48% over the past month. Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Previous Close:
$15.67
Open:
$15.38
24h Volume:
374,187
Relative Volume:
1.12
Market Cap:
$1.97B
Revenue:
$65.48M
Net Income/Loss:
-$94.46M
P/E Ratio:
-
EPS:
-$0.7375
Net Cash Flow:
-$71.18M
1W Performance:
+23.45%
1M Performance:
+3.48%
6M Performance:
-3.25%
1Y Performance:
-7.73%
1-Day Range:
$14.84$15.69
1-Week Range:
$12.33$15.82
52-Week Range:
$11.89$21.50
Mesoblast Ltd Adr Stock (MESO) Company Profile
Compare MESO vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MESO Mesoblast Ltd Adr | $15.16 | $1.97B | $65.48M | -$94.46M | -$71.18M | -$0.7375 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades
Mesoblast Ltd Adr Stock (MESO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mesoblast Ltd Adr Stock (MESO) Insider Trading
- George GregoryApr 10 '26Director
- Transaction
- Buy
- Cost
- $1.48
- #Shares
- 2,324,072
- Value ($)
- 3,439,627
- #Shares Total
- 8,324,072
- George GregoryApr 10 '26Director
- Transaction
- Buy
- Cost
- $1.48
- #Shares
- 2,324,072
- Value ($)
- 3,439,627
- #Shares Total
- 8,324,072
- George GregoryApr 09 '26Director
- Transaction
- Buy
- Cost
- $1.44
- #Shares
- 1,586,890
- Value ($)
- 2,277,350
- #Shares Total
- 13,586,890
- George GregoryApr 09 '26Director
- Transaction
- Buy
- Cost
- $8.59
- #Shares
- 1,981,890
- Value ($)
- 17,015,467
- #Shares Total
- 13,586,890
- George GregoryApr 04 '26Director
- Transaction
- Buy
- Cost
- $1.42
- #Shares
- 4,000,000
- Value ($)
- 5,680,000
- #Shares Total
- 12,000,000
